Responding to the Science – Biologics in Practice in COPD - CME - Guideline Central

CME

Title
Responding to the Science – Biologics in Practice in COPD
Link
Description
This enduring podcast activity provides pulmonologists and clinicians managing COPD with timely updates on the evolving role of biologics management. Featuring expert discussions, the program explores recent GOLD guideline revisions, the integration of new and emerging biologic therapies, and evidence-based decision-making based on clinical trial data and real-world practice. Covering guidelines, clinical trials, and clinical scenario, this activity emphasizes the translation of complex data into practical strategies. Learners will gain improved knowledge and competence related to patient selection, eosinophil thresholds, and clinical decision making.
Target Audience
The target audience for this program will include pulmonologists, allergists/immunologists, and critical care medicine physicians (MDs, DOs), nurse practitioners (NPs) and physician associates/physician assistants (PAs) practicing in these specialties; as well as primary care clinicians (MDs, DOs, NPs, and PAs) and geriatricians caring for patients with or at risk for COPD.
Learning Objectives
  • Discuss recent evidence surrounding the use of biologic agents in the management of patients with COPD, including patient populations and outcomes
  • Integrate the use of biologic agents into the management of patients with COPD based on guidelines and clinical evidence for new and emerging agents
Estimated Duration
15 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Pulmonology, Geriatric Medicine, Critical Care, Allergy and Immunology, Primary Care
Keywords
chronic obstructive pulmonary disease (COPD), COPD, Biologic therapies
Disclosures and Disclaimers
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of NACE, APAPP, GSK, or Regeneron Pharmaceuticals, Inc and Sanofi. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Accredited Providers
  • National Association for Continuing Education
  • Association for Pulmonary Advanced Practice Providers (APAPP)
Commercial Support
  • Regeneron Pharmaceuticals, Inc
  • Sanofi US
  • GSK
Activity Expiration Date
December 12, 2026
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit0.25 CreditsACCME- Accreditation Council for Continuing Medical Education
Nursing0.25 Contact HoursAANP- American Association of Nurse Practitioners
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.